Latest news
RBC Capital Maintains Sionna Therapeutics(SION.US) With Sell Rating, Maintains Target Price $23 - MoomooMoomoo · Sat, 08 Aug 2026 10:51:39 GMTCould 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire? - The Motley FoolThe Motley Fool · Fri, 07 Aug 2026 19:00:00 GMTSionna Therapeutics, Inc. (SION) Stock Price, News, Quote & History - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 16:25:26 GMTSION SWOT Analysis: Financial Struggles Amid Promising Pipeline Revealed in 10-Q Filing - GuruFocusGuruFocus · Fri, 07 Aug 2026 06:16:12 GMTSionna Therapeutics (NASDAQ: SION) reports $56.7M H1 net loss - Stock TitanStock Titan · Thu, 06 Aug 2026 22:53:05 GMTSionna Therapeutics, Inc. Stock 12‑Month Price Target Raised to $53.2, Implies 12% Upside - TradingViewTradingView · Thu, 06 Aug 2026 20:24:28 GMTSionna Therapeutics Releases Q2 2026 Financial Results - AlphaStreetAlphaStreet · Thu, 06 Aug 2026 14:34:35 GMTSionna Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 13:21:26 GMT